These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26972002)

  • 1. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein.
    Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M
    Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.
    Behrens AJ; Kumar A; Medina-Ramirez M; Cupo A; Marshall K; Cruz Portillo VM; Harvey DJ; Ozorowski G; Zitzmann N; Wilson IA; Ward AB; Struwe WB; Moore JP; Sanders RW; Crispin M
    J Proteome Res; 2018 Mar; 17(3):987-999. PubMed ID: 29420040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers.
    Pritchard LK; Vasiljevic S; Ozorowski G; Seabright GE; Cupo A; Ringe R; Kim HJ; Sanders RW; Doores KJ; Burton DR; Wilson IA; Ward AB; Moore JP; Crispin M
    Cell Rep; 2015 Jun; 11(10):1604-13. PubMed ID: 26051934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
    Pritchard LK; Spencer DI; Royle L; Bonomelli C; Seabright GE; Behrens AJ; Kulp DW; Menis S; Krumm SA; Dunlop DC; Crispin DJ; Bowden TA; Scanlan CN; Ward AB; Schief WR; Doores KJ; Crispin M
    Nat Commun; 2015 Jun; 6():7479. PubMed ID: 26105115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
    Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
    J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.
    Pritchard LK; Harvey DJ; Bonomelli C; Crispin M; Doores KJ
    J Virol; 2015 Sep; 89(17):8932-44. PubMed ID: 26085151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
    Crooks ET; Grimley SL; Cully M; Osawa K; Dekkers G; Saunders K; Rämisch S; Menis S; Schief WR; Doria-Rose N; Haynes B; Murrell B; Cale EM; Pegu A; Mascola JR; Vidarsson G; Binley JM
    PLoS Pathog; 2018 May; 14(5):e1007024. PubMed ID: 29718999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
    J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.
    Doores KJ; Bonomelli C; Harvey DJ; Vasiljevic S; Dwek RA; Burton DR; Crispin M; Scanlan CN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13800-5. PubMed ID: 20643940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
    LaBranche CC; McGuire AT; Gray MD; Behrens S; Kwong PDK; Chen X; Zhou T; Sattentau QJ; Peacock J; Eaton A; Greene K; Gao H; Tang H; Perez LG; Chen X; Saunders KO; Kwong PD; Mascola JR; Haynes BF; Stamatatos L; Montefiori DC
    PLoS Pathog; 2018 Nov; 14(11):e1007431. PubMed ID: 30395637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
    Bonomelli C; Doores KJ; Dunlop DC; Thaney V; Dwek RA; Burton DR; Crispin M; Scanlan CN
    PLoS One; 2011; 6(8):e23521. PubMed ID: 21858152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
    Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ
    Retrovirology; 2014 May; 11():41. PubMed ID: 24884783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.
    Sun L; Ishihara M; Middleton DR; Tiemeyer M; Avci FY
    J Biol Chem; 2018 Sep; 293(39):15178-15194. PubMed ID: 30115684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.
    Cao L; Diedrich JK; Kulp DW; Pauthner M; He L; Park SR; Sok D; Su CY; Delahunty CM; Menis S; Andrabi R; Guenaga J; Georgeson E; Kubitz M; Adachi Y; Burton DR; Schief WR; Yates JR; Paulson JC
    Nat Commun; 2017 Mar; 8():14954. PubMed ID: 28348411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of the HIV-1 Env glycan shield across scales.
    Berndsen ZT; Chakraborty S; Wang X; Cottrell CA; Torres JL; Diedrich JK; López CA; Yates JR; van Gils MJ; Paulson JC; Gnanakaran S; Ward AB
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28014-28025. PubMed ID: 33093196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.
    Behrens AJ; Harvey DJ; Milne E; Cupo A; Kumar A; Zitzmann N; Struwe WB; Moore JP; Crispin M
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.